{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Aventura",
      "state": "FL",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "81436",
      "recalling_firm": "Zero Xtreme USA",
      "address_1": "20533 Biscayne Blvd # 825",
      "address_2": "",
      "postal_code": "33180-1529",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Press Release",
      "distribution_pattern": "Nationwide within the USA.",
      "recall_number": "D-0246-2019",
      "product_description": "Zero Xtreme Dietary Supplement 30-count capsules.  By:Zero Xtreme Registro Sanitario No SD2014-0002208 LLC-USA",
      "product_quantity": "16 bottles",
      "reason_for_recall": "Marketed Without an Approved NDA/ANDA: Undeclared Sibutramine",
      "recall_initiation_date": "20181015",
      "center_classification_date": "20181115",
      "termination_date": "20220118",
      "report_date": "20181121",
      "code_info": "Lot: 1220062085 Exp. 03/2020",
      "more_code_info": ""
    }
  ]
}